By Mary Chapman Lupus News Today Copyright © 2013-2018 All rights reserved. Completion of a second round of funding could help bring closer to market Progentec Diagnostics‘ new tool for predicting lupus flares and a biomarker-based index that monitors underlying disease activity. Funding for Progentec’s biomarker-based diagnostic testing was led by venture capital outfits i2ERead more
News
– New funding brings lupus-detection tools closer to commercialization – Acquisition of LupusCorner marks a step forward in developing a first-in-class lupus-management platform OKLAHOMA CITY, Nov. 1, 2018 /PRNewswire/ — Progentec Diagnostics, Inc. (“Progentec”), a leader in the development of technological innovations in the field of diagnostics, today announced the completion of a second roundRead more
By Scott Meacham Copyright © 2017, The Oklahoma Publishing Co. Over the last year, Progentec Diagnostics, a startup that is focused on developing breakthrough diagnostics, has made significant progress on a diagnostic test to identify patients at increased risk for flare in lupus. Lupus is a viciously painful disease that generally surfaces in women inRead more
By Jim Stafford Copyright © 2017, The Oklahoma Publishing Co. Seated next to each other on a stage Tuesday morning at the Oklahoma Medical Research Foundation were the alpha and omega of Oklahoma City’s Selexys Pharmaceuticals. Dr. Rodger P. McEver and Russell Rother shared the stage as part of a panel discussion on “Relationship DynamicsRead more
I get really excited when I see an Oklahoma startup improving the lives of people who have incurable debilitating disease. That’s the story of Progentec Diagnostics, a startup that is focused on developing breakthrough diagnostics. The firm’s initial focus is on developing a diagnostic test to identify patients at increased risk for flare in lupus, an incurable autoimmune disease that afflicts 1.5 million patients in the U.S.
